Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial

Atsushi Tanaka(Friends United), Kazuomi Kario(University of Pennsylvania), Yukihito Higashi(Hiroshima University Hospital), Koji Maemura(Nagasaki University), Toyoaki Murohara(Nagoya University), Nobukazu Ishizaka(Osaka Medical and Pharmaceutical University), Katsumi Eguchi(Sasebo City General Hospital), Koichi Node(Saga University), Toru Kato(National Hospital Organization), Shinichiro Ueda(University of the Ryukyus), Jun‐ichi Oyama(Saga University), Akira Sezai(Nihon University), Hiroki Teragawa(Hiroshima General Hospital), Masataka Sata(Tokushima University), Tomoko Ishizu(University of Tsukuba), Ryoichi Ishibashi(Kisarazu Hospital), Yumiko Kanzaki(Osaka Medical and Pharmaceutical University), Isao Taguchi(Dokkyo Medical University Saitama Medical Center), Hirofumi Tomiyama(Tokyo Medical University), Hirotsugu Yamada(Tokushima University Hospital), Mitsuru Ohishi(Kagoshima University), Shigeru Toyoda(Dokkyo Medical University), Kotaro Yokote(Chiba University)
PLoS Medicine
April 22, 2020
Cited by 100


Related Papers